Shopping Cart
- Remove All
Your shopping cart is currently empty
JHU-083
🥰Excellent
Catalog No. T15613Cas No. 1998725-11-3
Alias JHU083
JHU-083 is an orally available, blood-brain barrier-crossing, selective glutaminase antagonist that improves cognitive performance and normalizes abnormal hippocampal glutaminase activity in APOE4 mice.
JHU-083
🥰Excellent
Purity: 99.53%
Catalog No. T15613Alias JHU083Cas No. 1998725-11-3
JHU-083 is an orally available, blood-brain barrier-crossing, selective glutaminase antagonist that improves cognitive performance and normalizes abnormal hippocampal glutaminase activity in APOE4 mice.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $222 | In Stock | |
| 5 mg | $469 | In Stock | |
| 10 mg | $768 | In Stock | |
| 25 mg | $1,460 | In Stock | |
| 50 mg | $1,880 | In Stock | |
| 100 mg | $2,480 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
View MoreBatch Information
Select Batch
Purity:99.53%
ee:96.08%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | JHU-083 is an orally available, blood-brain barrier-crossing, selective glutaminase antagonist that improves cognitive performance and normalizes abnormal hippocampal glutaminase activity in APOE4 mice. |
| In vivo | JHU-083 (1.82 mg/kg; orally; every other day for 12 days) was able to alleviate CSDS-induced social avoidance behaviors as well as behaviors resembling pleasure deprivation. JHU-083 (1.82 mg/kg; orally) reduced the magnitude of CSDS-induced enhancement of glutaminase activity in CD11b+ cells in the prefrontal cortex and hippocampus, but had no significant effect on cerebellar enzyme activity. In addition, JHU-083 treatment down-regulated the CSDS-induced expression levels of IL-1β and TNF-α. [1] |
| Synonyms | JHU083 |
| Molecular Weight | 312.37 |
| Formula | C14H24N4O4 |
| Cas No. | 1998725-11-3 |
| Smiles | [C@H](NC([C@H](CC(C)C)N)=O)(CCC(C=[N+]=[N-])=O)C(OCC)=O |
| Relative Density. | no data available |
Storage & Solubility Information
| Storage | keep away from moisture,store at low temperature,The compound is unstable in solution. Please use soon | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | PBS (pH 7.2): 20 mg/mL (64.03 mM), Sonication is recommended.The compound is unstable in solution. Please use soon. DMSO: 80 mg/mL (256.11 mM), Sonication is recommended.The compound is unstable in solution. Please use soon. Ethanol: 120 mg/mL (384.16 mM), Sonication is recommended.The compound is unstable in solution. Please use soon. H2O: 30 mg/mL (96.04 mM), Sonication is recommended.The compound is unstable in solution. Please use soon. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (10.56 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
PBS (pH 7.2)/H2O/DMSO/Ethanol
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy JHU-083 | purchase JHU-083 | JHU-083 cost | order JHU-083 | JHU-083 chemical structure | JHU-083 in vivo | JHU-083 formula | JHU-083 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.